Back to dashboard
CommercialBilling CodesMedium impact

Daptomycin

Blue Cross & Blue Shield of Mississippi·MS · Infectious Disease, Internal Medicine, Family Medicine +2 more·Medical Policy
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply

Summary

BCBS Mississippi updated their daptomycin (Cubicin) policy with revised age criteria for bloodstream infections and added new HCPCS billing codes. The policy now specifies that patients 18+ (instead of adults generally) with S. aureus bacteremia including right-sided endocarditis are covered, and added four new manufacturer-specific HCPCS codes for different daptomycin formulations.

Action Required

Action needed
Immediately: Update billing system to include new HCPCS codes J0872, J0873, J0874, and J0877 for different daptomycin manufacturers. Ensure prior authorization process verifies patient age 18+ for S. aureus bacteremia cases (previously just 'adults'). Add new ICD-10 codes L02.217, L02.227, L03.31A, and L03.32A to covered diagnosis list. Verify infectious disease specialist consultation requirement is documented for all daptomycin prior authorizations.

Affected Billing Codes

J0872
J0873
J0874
J0877
J0878
A41.01
A41.02
A49.01
A49.02
B95.0
B95.1
B95.2
B95.4
B95.61
L02.217
L02.227
L02.212
L02.222
L03.31A
L03.32A
L03.213